Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

FP5

COELIAC-EU/CLUSTER Informe resumido

Project ID: QLK1-CT-1999-00037
Financiado con arreglo a: FP5-LIFE QUALITY
País: Finland

Establishment of prevalence of coeliac disease based on serum IgA-class t-Tgase antibody positivity in randomly selected population samples of adults

Establishment of prevalence of coeliac disease based on serum IgA-class t-Tgase antibody positivity in randomly selected population samples of adults in 4 different European Member States ( Finland, Germany, Italy and Ireland), and in children in 2 Member States (Ireland and Italy.

The aim of the Coeliac-EU Cluster Epidemiology was to establish the prevalence of coeliac disease and tissue transglutaminase antibody positivity in four European countries using a large population-based screening approach. This study confirm the prevalence of coeliac disease in Europe. Average prevalence 1:100.

Howerver, the study showed that there are true differences among populations. Coeliac disease is five to ten times less frequent in Germany than in Finland, Italy or Northern Ireland, UK.

Contacto

Markku MÄKI, (Professor of paediatrics)
Tel.: +358-3-2157724
Fax: +358-3-2157746
Correo electrónico
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba